Enterprise Therapeutics is a startup based in the United Kingdom, 2 tracked investors.
Based in the United Kingdom, Enterprise Therapeutics is a startup. Brouky records 2 investors associated with the company.
Enterprise Therapeutics develops novel therapies targeting ion channels for the treatment of respiratory diseases such as cystic fibrosis and chronic obstructive pulmonary disease (COPD).
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.